TP 3654,
TP3654,
vasoactive intestinal peptide-Aba-Gly-Gly-Ala-Gly,
VIP-Aba-Gly-Gly-(D)-Ala-Gly,
VIP-aminobutyric acid-glycyl-glycyl-(D)-alanyl-glycine,
TP-3654,
1361951-15-6,
UNII-EOB0N7BOY4,
TP3654,
EOB0N7BOY4,
SCHEMBL102560,
CHEMBL3975308,
SCHEMBL19986953,
SCHEMBL20794171,
BDBM242374,
EX-A1828,
SGI-9481,
AKOS032960444,
CS-6293,
SB17245,
HY-101126,
AK00792306,
US9416132, 8-31,
2-((1r,4r)-4-((3-(3-(trifluoromethyl)phenyl)imidazo[1,2-b]pyridazin-6-yl)amino)cyclohexyl)propan-2-ol,
2-(4-((3-(3-(Trifluoromethyl)phenyl)imidazo(1,2-b)pyridazin-6-yl)amino)cyclohexyl)propan-2-ol,
4-((3-(3-(Trifluoromethyl)phenyl)imidazo(1,2-b)pyridazin-6-yl)amino) -trans-cyclohexyl)propan-2-ol,